REVIEW
|
doi:10.20944/preprints202106.0158.v1
Online: 7 June 2021 (09:29:06 CEST)
ARTICLE
|
doi:10.20944/preprints201805.0088.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
p53; proteasome inhibitor; endometrial cancer; ovarian cancer; gain-of-function mutation
Online: 4 May 2018 (09:03:27 CEST)